New investigational drug for endometrial cancer

Trial ID:
IRB-25-8667
Jo Marie Tran Janco, MD

Inclusion Criteria

Patients must:

  • Be female and 18 years or older
  • Have confirmed diagnosis of endometrial carcinoma
  • Have 1 or 2 prior lines of therapy

Exclusion Criteria

Patients must not:

  • Had uterine sarcomas
  • Have active or prior documented autoimmune inflammatory disorders
  • Have recurrence of endometrial carcinoma
  • Be pregnant or breastfeeding

Additional Info

All treatments and physician visits during the study will take place at Prebys Cancer Center in Hillcrest. Study participation will last up to 12 months.

For more information search NCT07044336 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org